Trial Profile
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary) ; Umirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms Grand-DES
- 27 Apr 2018 New trial record